| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Revenue | — | — | — |
| Cost of Revenue | — | — | — |
| Gross Profit | — | — | — |
| R&D Expense | — | — | — |
| SG&A Expense | — | — | — |
| Operating Income | — | — | — |
| Net Income | $-0.5B | $0.3B | $-0.1B |
| EPS (Basic) | $-1.35 | $0.36 | $-0.43 |
| EPS (Diluted) | $-1.35 | $0.34 | $-0.43 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Total Assets | $6.8B | $7.9B | $7.9B |
| Current Assets | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $2.2B | $2.6B | $2.7B |
| Current Liabilities | — | — | — |
| Stockholders' Equity | $3.0B | $3.7B | $3.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.3B | $-0.2B |
| Investing Cash Flow | — | — | — |
| Capital Expenditures | — | — | — |
| Financing Cash Flow | $-0.6B | $-0.3B | $0.3B |